Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Recursion Pharmaceuticals Inc (RXRX) vs Vertiv Holdings Co (VRT) Price & Performance

Recursion Pharmaceuticals IncTrade
Vertiv Holdings CoTrade

Price performance (Past 24H)

Key statistics

Recursion Pharmaceuticals Inc vs Vertiv Holdings Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Vertiv Holdings Co trades at $305.56 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 73.2× Recursion Pharmaceuticals Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

RXRXVRT
Market Cap
$1.53B$112.03B
Sector
HealthTechnology
52-Week High
$6.79$376.23
52-Week Low
$2.84$121.82
Enterprise Value
$946.50M$112.80B
Dividend Yield
0.09%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX

About Vertiv Holdings Co

Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.

Read more on VRT